26 June 2018
Liz Doolin
Dear Liz
This letter supersedes the letter of 21 June 2010 which is hereby revoked.
After completing a number of reviews at the end of the financial year, including your salary, I am pleased to advise that your Total Remuneration Package will increase, effective from 1 July 2018.
| | | | | | | | | | | | | | | | |
| | | | | | Current | | | | | | New | |
Base Salary | | | | | | $ | 147,031.96 | | | | | | | $ | 164,383.56 | |
Superannuation | | | 9.50 | % | | $ | 13,988.04 | | | | 9.50 | % | | $ | 15,616.44 | |
Total Remuneration Package | | | | | | $ | 161,000.00 | | | | | | | $ | 180,000.00 | |
Thank you for your loyalty, support and continued contribution to Bionomics and its achievements over the last year.
In recognition of the company’s achievements, and your personal goals in the 2017/2018 financial year, you will be paid a bonus of $9,056,25 which will be paid 50% in cash and 50% in Bionomics shares. The issue of Bionomics shares is subject Board determination of the issue price at the August Board Meeting and will be issued following the meeting,
I would like to congratulate you on your achievements this year and confirm your promotion to Vice President, Clinical Development.
As we continue to execute on our business strategy, I look forward to working with you in achieving our goals during this exciting time at Bionomics.
With best wishes
/s/ Deborah Rathjen
Deborah Rathjen
CEO & Managing Director
Bionomics Limited ABN 53 075 582 740
31 Dalgleish Street Thebarton SA Australia 5031 Phone 61 8 8354 6100 Fax 61 8 8354 6199 Email info@bionomics.com.au
website www.bionomics.com.au
